SHENZHEN, China, Dec. 31, 2012 /PRNewswire-FirstCall/ -- Mindray
Medical International Limited ("Mindray", NYSE: MR), a leading
developer, manufacturer and marketer of medical devices worldwide,
today announced shareholder resolutions adopted at its annual
general meeting of shareholders held in Hong Kong on December
28,2012.
At the meeting, Mindray shareholders approved the re-election of
incumbent directors Xu Hang,
Ronald Ede and Chen Qingtai, each to
serve a three-year term.
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the Company's independent registered
public accounting firm for the fiscal year ending December 31, 2012.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain our global headquarters
in Shenzhen, China, U.S.
headquarters in Mahwah, New Jersey and multiple sales
offices in major international markets. From our main manufacturing
and engineering base in China, we supply through our worldwide
distribution network a broad range of products across three primary
business segments, namely patient monitoring and life support,
in-vitro diagnostic, and medical imaging systems. For more
information, please visit http://ir.mindray.com.
For investor and media inquiries please contact:
In the U.S:
Hoki Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email: hoki.luk@westernbridgegroup.com
In China:
Cathy Gao
Mindray Medical International Limited
Tel: +86-755-8188-8023
Email: cathy.gao@mindray.com
SOURCE Mindray Medical International Limited